Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000134.xml
Diabetologie und Stoffwechsel 2021; 16(S 02): S406-S422
DOI: 10.1055/a-1507-2545
DOI: 10.1055/a-1507-2545
DDG-Praxisempfehlung
Diabetes und Migration
Die DDG-Praxisempfehlungen werden regelmäßig zur zweiten Jahreshälfte aktualisiert. Bitte stellen Sie sicher, dass Sie jeweils die neueste Version lesen und zitieren.
Änderung 1: Besonderheiten in der Diagnostik
Begründung: Der HbA1c-Wert wird zur Diabetesdiagnose, zur Identifizierung von Personen mit erhöhtem Diabetesrisiko und zur Bewertung der Diabeteseinstellung verwendet. Bei Eingewanderten und ihren Nachkommen können verschiedene Veränderungen den HbA1c-Wert beeinflussen oder verfälschen. Dadurch kann es im klinischen Alltag zu Fehlinterpretationen in der Diabetesdiagnose und eventuell zu falschen Therapieentscheidungen kommen.
Stützende Quellenangaben: [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36]
Änderung 2: Besonderheiten in der Therapie
Begründung: Es gibt Hinweise darauf, dass sich die Therapie abhängig von der kulturellen Zugehörigkeit unterscheidet. Trotz vorhandener neuer Diabetestherapeutika mit nachgewiesenen Effekten auf verschiedene Diabetesendpunkte ist deren Einsatz nicht in allen geografischen Regionen und Bevölkerungsgruppen gleich.
Stützende Quellenangaben: [37] [38]
Änderung 3: Besonderheiten in der Substanzauswahl
Begründung: Inwieweit spielt die Ethnizität bei den interindividuellen Wirkungsunterschieden verschiedener Diabetestherapeutika eine Rolle?
Publication History
Article published online:
21 October 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
-
1 www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Migration-Integration/Methoden/migrationshintergrund.html?nn=208952
- 2 Robert Koch-Institut, Hrsg. Gesundheit in Deutschland. Gesundheitsberichtserstattung des Bundes. Gemeinsam getragen von RKI und Destatis. Berlin: RKI; 2015 DOI: 10.17886/rkipubl-2015-003-3
- 3 Berger F. Typ-2-Diabetes und Migranten: Menschen aus verschiedenen Sprach- und Kulturräumen. Diabetologie 2018; 13: 241-255 DOI: 10.1055/s-0043-124751.
- 4 Statistisches Bundesamt, Wiesbaden. Pressemitteilung Nr. 279 vom 28. Juli 2020. Im Internet (Stand: 28.07.2020): http://www.destatis.de/DE/Presse/Pressemitteilungen/2020/07/PD20_279_12511.html
- 5 Statistisches Bundesamt, Wiesbaden. Pressemitteilung Nr. 261 vom 1. August 2017. Im Internet (Stand: 03.05.2019): www.destatis.de/DE/Presse/Pressemitteilungen/2017/08/PD17_261_12511.html
- 6 Bundesamt für Migration und Flüchtlinge. Das Bundesamt in Zahlen 2017, Asyl, Migration und Integration. Nürnberg: BAMF; 2018 Im Internet (Stand: 03.05.2019): www.bamf.de/SharedDocs/Anlagen/DE/Publikationen/Broschueren/bundesamt-in-zahlen-2017.html
- 7 Jacobs E, Rathmann W. Epidemiologie des Diabetes. Diabetologie und Stoffwechsel 2017; 12 (06) 437-446 DOI: 10.1055/s-0043-120034.
- 8 Tenkorang EY. Early onset of type 2 diabetes among visible minority and immigrant populations in Canada. Ethnicity & Health 2017; 22 (03) 266-284 DOI: 10.1080/13557858.2016.1244623.
- 9 Aydinkoc K. et al Diabetesprävalenz und Diabetes-spezifisches Wissen bei türkischen MigrantInnen. ÖDG-Herbsttagung 2011, S. 28. Im Internet (Stand: 11.06.2018): www.oedg.at/pdf/1111_OEDG_JT_Programm.pdf
- 10 Meeks KA, Freitas-Da-Silva D, Adeyemo A. et al. Disparities in type 2 diabetes prevalence among ethnic minority groups resident in Europe: a systematic review and meta-analysis. Internal and Emergency Medicine 2016; 11 (03) 327-340 DOI: 10.1007/s11739-015-1302-9.
- 11 Ujcic-Voortman JK, Schram MT, Jacobs-van der Bruggen MA. et al. Diabetes prevalence and risk factors among ethnic minorities. European Journal of Public Health 2009; 19 (05) 511-515 DOI: 10.1093/eurpub/ckp096.
- 12 Stirbu I, Kunst AE, Bos V. et al. Differences in avoidable mortality between migrants and the native Dutch in The Netherlands. BMC Public Health 2006; 6: 78 DOI: 10.1186/1471-2458-6-78.
- 13 Li X, Sundquist J, Zöller B. et al. Risk of hospitalization for type 2 diabetes in first- and second-generation immigrants in Sweden: a nationwide follow-up study. Journal of Diabetes and its Complications 2013; 27 (01) 49-53 DOI: 10.1016/j.jdiacomp.2012.06.015.
- 14 Vandenheede H, Deboosere P, Stirbu I. et al. Migrant mortality from diabetes mellitus across Europe: the importance of socio-economic change. European Journal of Epidemiology 2012; 27 (02) 109-117 DOI: 10.1007/s10654-011-9638-6.
- 15 Sivaprasad S, Gupta B, Gulliford MC. et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One 2012; 7: e32182 DOI: 10.1371/journal.pone.0032182.
- 16 Reeske A, Zeeb H, Razum O. et al. Differences in the Incidence of Gestational Diabetes between Women of Turkish and German Origin: An Analysis of Health Insurance Data From a Statutory Health Insurance in Berlin, Germany (AOK), 2005-2007. Geburtshilfe und Frauenheilkunde 2012; 72 (04) 305-310 DOI: 10.1055/s-0031-1280428.
- 17 Migration und Integration. Statistisches Jahrbuch 2020, Statistik Austria und Bundeskanzleramt – Sektion Integration. Online: Statistisches_Jahrbuch_migration_integration_2020.pdf
- 18 Schmutterer I, Delcour J, Griebler R, Hrsg. Österreichischer Diabetesbericht 2017. Wien: Bundesministerium für Gesundheit und Frauen; 2017
- 19 IDF – Diabetes Atlas 8th Edition 2017. Im Internet (Stand: 15. Juli 2018): www.diabetesatlas.org/acrossthe-globe.html
- 20 Aydinkoc K, Fasching P, Taskiran T. et al Diabetesprävalenz und Diabetes-spezifisches Wissen bei türkischen MigrantInnen, ÖDG-Herbsttagung. 2011: S. 28 www.oedg.org/pdf/1111_OEDG_JT_Programm.pdf . Zugegriffen: 11. Juni 2018
- 21 Bundesministerium für Gesundheit. Statistik A. Österreichische Gesundheitsbefragung 2006/2007. Familie und Jugend. Sozio-demografische und sozioökonomische Determinanten von Gesundheit. 2007
- 22 Kirkcaldy B, Wittig U, Furnham A. et al. Migration und Gesundheit. Psychosoziale Determinanten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006; 49 (09) 873-883
- 23 White JS, Hamad R, Li X. et al. Long-term effects of neighbourhood deprivation on diabetes risk: quasi-experimental evidence from a refugee dispersal policy in Schweden. Lancet Diabetes & Endocrinology 2016; 4 (06) 517-524 DOI: 10.1016/S2213-8587(16)30009-2.
- 24 Statistik A. Österreichische Gesundheitsbefragung 2006/2007. Bundesministerium für Gesundheit, Familie und Jugend. Soziodemografische und sozioökonomische Determinanten von Gesundheit. 2007
- 25 Petersmann A, Müller-Wieland D, Müller Ulrich A. et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 2019; 127 (Suppl. 01) 1-7 DOI: 10.1055/a-1018-9078.
- 26 Unnikrishnan R, Anjana RM, Mohan V. Drugs affecting HbA1c levels. Indian journal of endocrinology and metabolism 2012; 16 (04) 528-531 DOI: 10.4103/2230-8210.98004.
- 27 Cohen RM, Haggerty S, Herman WH. HbA1c for the diagnosis of diabetes and prediabetes: Is it time for a mid-course correction?. J Clin Endocrinol Metab 2010; 95 (12) 5203-5206
- 28 Hinzmann R, Schlaeger C, Tran CT. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes?. Int J Med Sci 2012; 9: 665-681
- 29 Florkowski C. HbA as a diagnostic test for diabetes mellitus – reviewing the evidence. Clin Biochem Rev 2013; 34: 75-84
- 30 Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: Implications for the diagnosis of diabetes. J Clin Endocrinol Metab 2012; 97: 1067-1072
- 31 Zemlin AE, Matsha TE, Kengne AP. et al. Derivation and validation of an HbA1c optimal cutoff for diagnosing prediabetes in a South African mixed ancestry population. Clin Chim Acta 2015; 488: 215-219
- 32 Gordon DK, Hussain M, Kumar P. et al. The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability. Cureus 2020; 12 (08) e9685 DOI: 10.7759/cureus.9685.
- 33 Booth R, Jiang Y, Morrison H. et al. Ethnic dependent differences in diagnostic accuracy of glycated hemoglobin (HbA1c) in Canadian adults. Diabetes Res Clin Pract 2018; (136) 143-149
- 34 Wheeler E, Leong A, Liu CT. et al. Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS medicine 2017; 14 (09) e1002383 DOI: 10.1371/journal.pmed.1002383.
- 35 Klonoff DC. Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus. Journal of diabetes science and technology 2020; 14 (01) 3-7 DOI: 10.1177/1932296819841698.
- 36 Weatherall DJ. The evolving spectrum of the epidemiology of thalassemia. Hematol Oncol Clinics North Am 2018; 32: 165-175
- 37 Mathur R, Farmer RE, Eastwood SV. et al. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study. PLoS medicine 2020; 17 (05) e1003106 DOI: 10.1371/journal.pmed.1003106.
- 38 Eberly LA, Yang L, Eneanya ND. et al. Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US. JAMA network open 2021; 4 (04) e216139 DOI: 10.1001/jamanetworkopen.2021.6139.
- 39 Cai XL, Ji LN. Treatment response between Asian and non-Asian patients with type 2 diabetes: is there any similarity or difference?. Chinese medical journal 2019; 132 (01) S. 1-S. 3 DOI: 10.1097/CM9.0000000000000012.
- 40 Rashid M, Shahzad M, Mahmood S. Variability in the therapeutic response of Metformin treatment in patients with type 2 diabetes mellitus. Pakistan journal of medical sciences 2019; 35 (01) S. 71-S. 76 DOI: 10.12669/pjms.35.1.100.
- 41 Ito Y, Ambe K, Kobayashi M. et al. Ethnic difference in the pharmacodynamics-efficacy relationship of dipeptidyl peptidase-4 inhibitors between Japanese and non-Japanese patients: a systematic review. Clin Pharmacol Ther 2017; 102 (04) 701-708
- 42 Kim YG, Hahn S, Oh J. et al. Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis. Diabetes Obes Metab 2014; 16 (10) 900-909
- 43 Geiser JS, Heathman MA, Cui X. et al. Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials. Clinical pharmacokinetics 2016; 55 (05) S. 625-S. 634 DOI: 10.1007/s40262-015-0338-3.
- 44 DeSouza C. Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials. The Journal of clinical endocrinology and metabolism 2020; 105 (02) DOI: 10.1210/clinem/dgz072.
- 45 Scheen AJ. SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients. Diabetes, metabolic syndrome and obesity: targets and therapy 2020; 13: 2765-2779 DOI: 10.2147/DMSO.S193528.
- 46 Diker O, Deniz T, Çetinkaya A. History of Turkish Cuisine Culture and the Influence of the Balkans. IOSR Journal of Humanities And Social Science 2016; 21 (10) 01-06 DOI: 10.9790/0837-2110060106.
- 47 Schmid B. Ernährung und Migration, Empirische Untersuchungen zum Ernährungsverhalten italienischer, griechischer und türkischer Migrantinnen in Deutschland. München: Herbert UTZ Verlag; 2003 Kapitel 1, S. 9
- 48 Magni P, Bier DM, Pecorelli S. et al. Perspective: Improving Nutritional Guidelines for Sustainable Health. Advances in Nutrition 2017; 8 (04) 532-545 DOI: 10.3945/an.116.014738.
- 49 Mora N, Golden SH. Understanding Cultural Influences on Dietary Habits in Asian, Middle Eastern, and Latino Patients with Type 2 Diabetes: A Review of Current Literature and Future Directions. Current Diabetes Reports 2017; 17: 126 DOI: 10.1007/s11892-017-0952-6.
- 50 Weiss C, Oppelt P, Mayer RB. The participation rate of migrant women in gestational diabetes screening in Austria: a retrospective analysis of 3293 births. Arch Gynecol Obstet 2019; 299: 345-351
- 51 Pu J, Zhao B, Wang EJ. et al. Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk Factors. Paediatr Perinat Epidemiol 2015; 29: 436-443 DOI: 10.1111/ppe.12209.
- 52 Carolan M, Gill GK, Steele C. Women’s experiences of factors that facilitate or inhibit gestational diabetes self-management. BMC pregnancy and childbirth 2012; 12: 99 DOI: 10.1186/1471-2393-12-99.
- 53 El-Khoury Lesueur F, Sutter-Dallay AL, Panico L. et al. The perinatal health of immigrant women in France: a nationally representative study. International Journal of Public Health 2018; 63: 1027-1036 DOI: 10.1007/s00038-018-1146-y.
- 54 Eggemoen AR, Wiegels Waage C, Sletner L. et al Vitamin D, Gestational Diabetes and Measures of Glucose Metabolism in a Population-Based Multiethnic Cohort. J Diabetes Res 2018; 2018: 8939235 DOI: 10.1155/2018/8939235. . PMID: 29850611; PMCID: PMC5933024
- 55 Ziegler AG, Wallner M, Kaiser I. et al. Long-Term Protective Effect of Lactation on the Development of Type 2 Diabetes in Women with Recent Gestational Diabetes Mellitus. Diabetes 2012; 61: 3167-3171
- 56 Lange C, Schenk L, Bergmann R. Verbreitung, Dauer und zeitlicher Trend des Stillens in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsbl 2007; 50: 624-633
- 57 Shane AL. Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues. Emerg Infect Dis 2014; 20: 1961 DOI: 10.3201/eid2011.141052.
- 58 Berger F. Diabetes und Schwangerschaft bei Migrantinnen. In: Stupin JH, Schäfer-Graf U, Hummel M. Hrsg. Diabetes in der Schwangerschaft. Berlin: de Gruyter; 2020: 301-310
- 59 Hassanein M, Al-Arouij M, Hamdy O. et al. Diabetes and Ramadan: Practical guidelines. Diabetes Research and Clinical Practice 2017; 126: 303-316 DOI: 10.1016/j.diabres.2017.03.003.
- 60 International Diabetes Federation (IDF) and the Diabetes and Ramadan DAR International Alliance. Practical Guidelines. Brussels, Belgium: International Diabetes Federation; 2016: 108-114 www.idf.org/guidelines/diabetes-in-ramadan ; Stand: 25.07.2019
- 61 Salti I, Bénard E, Detournay B. et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27 (10) 2306-2311 DOI: 10.2337/diacare.27.10.2306.
- 62 Babineaux SM, Toaima D, Boye KS. et al. Multi-country retrospective observational study of management and outcomes of patients with type 2 diabetes during Ramadan in 2010(CREED). Diabetic Medicine 2015; 32 (06) 819-828 DOI: 10.1111/dme.12685.
- 63 Loh HH, Yee A, Loh HS. et al. Comparative studies of dipeptidyl peptidase 4 inhibitor vs sulphonylurea among Muslim Type 2 diabetes patients who fast in the month of Ramadan: A systematic review and meta-analysis. Primary Care Diabetes 2016; 10 (03) 210-219 DOI: 10.1016/j.pcd.2015.09.001.
- 64 Azis KMA. Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients, Kamran MAAziz. Diabetes Metabolic Syndrom and Obesity 2015; 16: 207-211 DOI: 10.2147/ DMSO. S54683.
- 65 Salem BA, Farooqi MH, Suliman SG. et al. Use of Sodium-Glucose Co-Transporter 2 Inhibitors during de Fasting of Ramadan: Is there cause for concern?. Ibnosina Journal of Medicine and Biomedical Sciences 2015; 8 (03) 81-88 DOI: 10.4103/1947-489X.210221.
- 66 Ali S, Davies MJ, Brady EM. et al. Guidelines for managing diabetes in Ramadan. Diabetic Medicine 2016; 33 (10) 1315-1329 DOI: 10.1111/dme.13080.
- 67 Ibrahim M, Davies MJ, Ahmad E. et al. Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. DOI: 10.1136/bmjdrc-2020-001248